2023-09-11 10:15:39 ET
More on Alnylam
- Seeking Alpha’s Quant Rating on Alnylam Pharmaceuticals
- Historical earnings data for Alnylam Pharmaceuticals
- Financial information for Alnylam Pharmaceuticals
- Alnylam Continues To Deliver, But An Upcoming FDA Meeting Could Create Some Volatility
- Alnylam: Unlimited Promise Or Unlimited Losses?
- Alnylam Pharmaceuticals, Inc. 2023 Q2 - Results - Earnings Call Presentation
- Alnylam Pharmaceuticals, Inc. ( ALNY ) Q2 2023 Earnings Call Transcript
- Alnylam succeeds in Phase 2 trial for blood pressure drug
- Alnylam picked for positive catalyst watch at Citi on amyloidosis therapy
- Alnylam appealing patent ruling in case against Moderna
- Roche, Alnylam in pact for blood pressure candidate
For further details see:
Alnylam amyloidosis drug led to “small” benefits in Phase 3 trial: FDA